Decentralized Point-of-Care Manufacturing of CD19 Chimeric Antigen Receptor T Cells in Mexico
Our study demonstrates an effective methodology with satisfactory and comparable performance to international reports. Point-of-care manufacturing is a feasible alternative to increase access to CAR-T cells in academic centers.
Authors
- David Gómez‐Almaguer (ORCID: https://orcid.org/0000-0002-0460-6427)
- Anna Cecilia Rodríguez-Zúñiga (ORCID: https://orcid.org/0000-0003-0546-5045)
- Andrés Gómez‐De León (ORCID: https://orcid.org/0000-0001-6904-9345)
- Nidia K. Moncada-Saucedo (ORCID: https://orcid.org/0000-0001-5055-4034)
- Rosario Salazar‐Riojas (ORCID: https://orcid.org/0000-0002-3213-5810)
- José Carlos Jaime‐Pérez (ORCID: https://orcid.org/0000-0001-6804-9095)
- Dalila Marisol Alvarado‐Navarro (ORCID: https://orcid.org/0000-0002-1264-8133)
- Yair Omar Chávez-Estrada (ORCID: https://orcid.org/0000-0002-8418-7655)
- Ana Karen Hernández-Navarro
- Martha Berenice Ake-Uc
- Sofía I. Quezada-Ramírez (ORCID: https://orcid.org/0000-0002-4732-3013)
Institutions
- Universidad Autónoma de Nuevo León (MX)
- Hospital Universitario Dr José Eleuterio Gonzalez (MX)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1200/go-24-00581
- Citations
- 4
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 4.18